IBD has headlines ready, but not full article reads yet. First headline: Musk To Pitch Terafab Semiconductor Factory To ASML Ahead Of SpaceX IPO
IBD Brief
What IBD is telling Charlie.
A plain-English IBD brief for Mike: what IBD said, what Charlie thinks it means, and whether anything deserves action.
Back to TodayCoverage auditToday's IBD read
No article summaries are ready yet.
Charlie should fall back to Schwab, Leaderboard, market data, and Schwab Research and avoid claiming IBD article-body evidence until this API source is readable again.
Read the article cards below first. Charlie should only turn an IBD item into Buy, Hold, Watch, or Do Nothing after checking Schwab position size, market data, research, and the stop plan.
Source warnings
Charlie needs to clean these up.
These are not tasks for Mike to figure out. Charlie can retry the source reads, and if a warning stays here, Charlie should treat that source as partial evidence.
Other caution
Refresh the source stack
Charlie can run the normal source refresh and then this page will update on its own. Mike does not need to diagnose these lines manually.
- IBD WordPress API 403: {"appId":"PXs0IVY1Pq","jsClientSrc":"/s0IVY1Pq/init.js","firstPartyEnabled":true,"vid":"","uuid":"c6d4f2a7-6692-11f1-8045-a0f3d906c8ae","hostUrl":"/s0IVY1Pq/xhr","blockScript":"/s0IVY1Pq/captcha/captcha.js?a=c&u=c6d4f2a7
- IBD cooldown active until 2026-06-12T19:17:25.898Z: Source returned a blocked, login-required, or browser-misconfigured state.
- Gmail token refresh failed: {"error":"invalid_grant","error_description":"Bad Request"}
Recommendation guardrail
IBD brief does not equal a buy signal.
Charlie can explain the IBD brief below, but he should not recommend a new buy unless the stock also fits Mike's rules, the current market, Schwab position size, and a clear stop plan.
IBD brief
Articles, market context, and IBD emails
IBD
IBD article brief
Jun 12, 2026, 12:13 PM
Needs login
What IBD says
IBD WordPress API 403: {"appId":"PXs0IVY1Pq","jsClientSrc":"/s0IVY1Pq/init.js","firstPartyEnabled":true,"vid":"","uuid":"c6d4f2a7-6692-11f1-8045-a0f3d906c8ae","hostUrl":"/s0IVY1Pq/xhr","blockScript":"/s0IVY1Pq/captcha/captcha.js?a=c&u=c6d4f2a7
Charlie's read
Charlie should fall back to Schwab, Leaderboard, market data, and Schwab Research and avoid claiming IBD article-body evidence until this API source is readable again.
IBD facts Charlie captured
No clean source facts captured yet.
IBD
IBD market read
Jun 12, 2026, 12:02 PM
Market read
What IBD says
IBD is signed in and the homepage can be read. Charlie did not capture a clean IBD market-exposure value yet. The deeper IBD Market Trend/Big Picture-style evidence is still not clean enough for buy calls.
Charlie's read
Charlie may use this only as proof the IBD session is alive. He should stay in no-buy mode until Market Trend, Big Picture, list, article, and per-ticker score coverage are readable.
IBD facts Charlie captured
- Blocked deeper IBD surface: IBD Big Cap 20: blocked.
IBD
IBD Leaderboard
Jun 12, 2026, 12:02 PM
Ready
What IBD says
Charlie captured the logged-in IBD Leaderboard page. Leaderboard is reachable, but Helm still needs cleaner list rows. This should be compared against the logged-in IBD 50/home-page member read, not the article feed.
Charlie's read
Charlie can use Leaderboard as IBD's member-only candidate universe and model-list context. It can help decide what deserves review next, but it is not a standalone buy signal and should be cross-checked against IBD account pages, Schwab, market data, and research context.
IBD facts Charlie captured
- Leaderboard is reachable, but Helm still needs cleaner list rows.
IBD
IBD Big Cap 20
Jun 12, 2026, 12:02 PM
Needs login
What IBD says
IBD displayed human-verification or access-denied copy on this deeper surface. That means the basic session can be alive while this specific page is still unusable.
Charlie's read
Charlie must tell Mike this source is blocked and avoid live buy/sell recommendations that depend on it.
IBD facts Charlie captured
- IBD Big Cap 20: blocked
IBD
IBD article reader
Jun 12, 2026, 12:02 PM
Needs review
What IBD says
No article tab is open in Helm Browser right now. The reader is ready, but it will only summarize article pages Mike or Will intentionally open.
Charlie's read
Charlie should not invent article summaries. He can ask Mike which IBD headline matters, then summarize the article after it is opened.
IBD facts Charlie captured
No clean source facts captured yet.
IBD
IBD headline feed
Jun 12, 2026, 12:13 PM
Headlines only
What IBD says
Musk To Pitch Terafab Semiconductor Factory To ASML Ahead Of SpaceX IPO (ASML)
Charlie's read
Charlie can use RSS as IBD headline awareness and article candidates, but should not treat it as subscriber article-body evidence.
IBD facts Charlie captured
- Musk To Pitch Terafab Semiconductor Factory To ASML Ahead Of SpaceX IPO
IBD
IBD emails
Jun 12, 2026, 12:13 PM
Not ready
What IBD says
IBD newsletter ingestion is ready, but Gmail/exported email input is not connected yet.
Charlie's read
Charlie should say the IBD email source is not connected before relying on newsletter context.
IBD facts Charlie captured
No clean source facts captured yet.
Supporting sources
Not the IBD brief, but Charlie checks these too
Mike finance inbox
Jun 12, 2026, 12:13 PM
Not ready
What the source says
Mike finance inbox is ready, but mikedmddavis@gmail.com is not authorized or has no imported finance emails yet.
Charlie's read
Charlie should say Mike's finance email source is not connected before relying on inbox context.
Source facts Charlie captured
No clean source facts captured yet.
RSS
Finance RSS headlines
Jun 12, 2026, 12:13 PM
Needs review
What the source says
CNBC Markets: Trump name still must come down from Kennedy Center, judge says | CNBC Markets: SpaceX market cap tops $2 trillion after shares of Elon Musk's rocket company gain 23% on debut | CNBC Markets: Goldman nets a big payday for SpaceX IPO. Plus, what drove our winners and losers this week | CNBC Markets: Small investors scrambled to get in on the SpaceX IPO, even as some believe the valuation is 'stupid' | CNBC Markets: Social Security COLA for 2027 may jump to 4.7%, one estimate finds. This chart shows prices driving the increase
Charlie's read
Charlie may use this as broad headline/chatter context only. It should not override IBD, Schwab, active source evidence, or Mike's rules.
Source facts Charlie captured
- Trump name still must come down from Kennedy Center, judge says
- SpaceX market cap tops $2 trillion after shares of Elon Musk's rocket company gain 23% on debut
- Goldman nets a big payday for SpaceX IPO. Plus, what drove our winners and losers this week
- Small investors scrambled to get in on the SpaceX IPO, even as some believe the valuation is 'stupid'
- Social Security COLA for 2027 may jump to 4.7%, one estimate finds. This chart shows prices driving the increase
Schwab
Schwab Ratings & Reports
Jun 12, 2026, 12:11 PM
Ready
What the source says
AVGO Schwab Equity Ratings: rating C, latest report June 12, 2026. | AVGO Morningstar: rating 4 stars, latest report June 4, 2026. | AVGO CFRA: rating 4 stars, latest report June 6, 2026. | AVGO Argus is present on Schwab Ratings & Reports. | BPTRX Morningstar: rating 1 stars. | ASML Schwab Equity Ratings: rating B, latest report June 12, 2026. | ASML Morningstar: rating 2 stars, latest report June 2, 2026. | ASML CFRA: rating 5 stars, latest report June 6, 2026.
Charlie's read
Charlie can use Schwab Research as a supporting evidence stack for ratings, valuation, quality, analyst context, short report excerpts, and report metadata. It should confirm or caution IBD/source evidence, not replace it.
Source facts Charlie captured
- AVGO Schwab Equity Ratings: rating C, latest report June 12, 2026.
- AVGO Morningstar: rating 4 stars, latest report June 4, 2026.
- AVGO CFRA: rating 4 stars, latest report June 6, 2026.
- AVGO Argus is present on Schwab Ratings & Reports.
- BPTRX Morningstar: rating 1 stars.
- ASML Schwab Equity Ratings: rating B, latest report June 12, 2026.
- ASML Morningstar: rating 2 stars, latest report June 2, 2026.
- ASML CFRA: rating 5 stars, latest report June 6, 2026.
- AVGO quote: last $380.77, bid $380.71, ask $380.82
- AVGO chart: -$4.81 (-1.25%), timeframes 1D, 5D, 1M, 3M, 6M, YTD, 1Y, 3Y, 5Y
- AVGO technicals: AVGO appears to be correcting within a longer-term bullish trend. Although its MACD is presently below the signal line, shares remain above an upwards sloping 200-day moving average. Comparative Relative Strength analysis shows that this issue is lagging the S&P 500.
- AVGO Schwab news: US STOCKS-S&P, Dow edge higher on Mideast deal hopes; SpaceX debut in focus (Reuters)
- AVGO dividend yield: 0.67%
- AVGO financial sections: earnings collapsed, peers/ratios collapsed, statements collapsed
- BPTRX chart: performance not captured, timeframes unknown
- BPTRX Schwab news: News Disclosures (Schwab Network is brought to you by Charles Schwab Media Productions Company (“CSMPC”). CSMPC and Charles Schwab & Co., Inc. are separate but affiliated subsidiaries of The Charles Schwab Corporation. CSMPC is not a financial advisor, registered investment advisor, broker-dealer, or futures commission merchant.)
- BPTRX financial sections: earnings readable, peers/ratios missing, statements missing
- ASML quote: last $1,873.51, bid $1,873.51, ask $1,874.12